Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy

BACKGROUND: Esophageal cancer is one of the most common malignant tumors in the world. With currently available therapies, only 20% ~ 30% patients can survive this disease for more than 5 years. TRAIL, a natural ligand for death receptors that can induce the apoptosis of cancer cells, has been explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Lujuan, Dai, Suli, Li, Zhirong, Zhang, Cong, Wei, Sisi, Zhao, Ruinian, Zhang, Hongtao, Zhao, Lianmei, Shan, Baoen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925860/
https://www.ncbi.nlm.nih.gov/pubmed/31864387
http://dx.doi.org/10.1186/s13046-019-1498-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925860/
https://www.ncbi.nlm.nih.gov/pubmed/31864387
http://dx.doi.org/10.1186/s13046-019-1498-z

Ejemplares similares